Potassium citrate
DrugBank ID: DB09125
Summary
| Metric | Value |
|---|---|
| Total Predictions | 50 |
| KG+DL (Dual Validated) | 3 |
| DL Only | 47 |
| KG Only | 0 |
Predictions
| Indication | Score | Source |
|---|---|---|
| renal tubular acidosis | 1.0000 | KG+DL |
| familial visceral myopathy | 0.9995 | DL |
| acute urate nephropathy | 0.9994 | KG+DL |
| mitochondrial oxidative phosphorylation disorder due to nuclear DNA anomalies | 0.9992 | DL |
| Pendred syndrome | 0.9988 | DL |
| nephrolithiasis | 0.9975 | DL |
| cystinosis | 0.9973 | DL |
| hypermanganesemia with dystonia | 0.9972 | DL |
| potassium deficiency disease | 0.9969 | KG+DL |
| nephrolithiasis susceptibility caused by SLC26A1 | 0.9968 | DL |
| autosomal recessive nonsyndromic deafness | 0.9967 | DL |
| exocrine pancreatic insufficiency | 0.9966 | DL |
| leukocyte adhesion deficiency | 0.9962 | DL |
| NAD(P)HX dehydratase deficiency | 0.9956 | DL |
| adult Fanconi syndrome | 0.9955 | DL |
| Fraser syndrome | 0.9952 | DL |
| Alstrom syndrome | 0.9950 | DL |
| temtamy preaxial brachydactyly syndrome | 0.9938 | DL |
| human HOXA1 syndromes | 0.9935 | DL |
| dyspepsia | 0.9927 | DL |
| glycogen storage disease due to GLUT2 deficiency | 0.9915 | DL |
| myopathic intestinal pseudoobstruction | 0.9895 | DL |
| unclassified intestinal pseudoobstruction | 0.9895 | DL |
| neuronal intestinal dysplasia, type B | 0.9884 | DL |
| exercise-induced malignant hyperthermia | 0.9880 | DL |
| primary Fanconi syndrome | 0.9863 | DL |
| intestinal obstruction | 0.9862 | DL |
| congenital short bowel syndrome 1 | 0.9850 | DL |
| osteopetrosis | 0.9850 | DL |
| HELIX syndrome | 0.9811 | DL |
| combined oxidative phosphorylation defect | 0.9809 | DL |
| deafness dystonia syndrome | 0.9798 | DL |
| malignant hyperthermia, susceptibility to | 0.9792 | DL |
| calcium-alkali syndrome | 0.9784 | DL |
| King-Denborough syndrome | 0.9770 | DL |
| urolithiasis | 0.9769 | DL |
| intestinal pseudoobstruction, neuronal, chronic idiopathic, X-linked | 0.9765 | DL |
| primary bone dysplasia | 0.9764 | DL |
| obsolete CFM1 | 0.9721 | DL |
| central core myopathy | 0.9716 | DL |
| neuronal intestinal pseudoobstruction | 0.9715 | DL |
| hypercalcemia disease | 0.9714 | DL |
| renal hypomagnesemia | 0.9702 | DL |
| congenital multicore myopathy with external ophthalmoplegia | 0.9691 | DL |
| moderate multiminicore disease with hand involvement | 0.9680 | DL |
| primary bone dysplasia with defective bone mineralization | 0.9658 | DL |
| immune-mediated necrotizing myopathy | 0.9644 | DL |
| antisynthetase syndrome | 0.9625 | DL |
| periodic paralysis (disease) | 0.9620 | DL |
| cytochrome-c oxidase deficiency disease | 0.9616 | DL |
External Links
Disclaimer
Predictions are for research purposes only and do not constitute medical advice.
Predictions are for research purposes only and do not constitute medical advice.